- Jet Nebulizer
- Ultrasonic Nebulizer
- Mesh Nebulizer
- Others
Inhalers And Nebulizers Market was valued at USD 5,976.3 million in 2023 and is poised to grow at a CAGR of 23.2% from 2024 to 2030. A nebulizer is a machine to spray a liquid mist of medicine with a mouthpiece or mask. It is electric or battery-powered machines that turn liquid medicine into a fine mist. Inhalers are little portable devices that can fit in hand and are small enough to carry in a backpack, purse, or pocket. There are two types of inhalers Metered dose inhalers (MDI) and Dry Powder Inhalers. Metered dose inhalers (MDI) are the most commonly used inhalers like little aerosol cans. The increasing prevalence of asthma and respiratory disorders is the major driver in the global inhalers and nebulizers market growth.
According to a report in ACAAI, 8.3% of Americans have asthma which is around 26.5 million, 20.4 million are adults and 6.1 million are children and asthma prevalence is higher in children (9.4 percent) than in adults (7.7 percent), and higher in females (9.2 percent) than males (7.0 percent). Moreover, an upsurge in air pollution is another reason for increasing respiratory diseases. For instance, according to Our World in Data, air pollution is attributed to 11.65% of deaths globally and death rates from air pollution are highest in low-to-middle-income countries. Along with these, growing demand for home healthcare devices, launches of innovative smart inhalers, and increasing use of inhalers will drive the global inhalers and nebulizers market growth. The global players are influencing the market through investment, innovations, and new product launches. However, the presence of alternative treatment options may hamper the global inhalers and nebulizers market growth.
Inhalers And Nebulizers Market Key Developments:
In July 2020, OMRON Healthcare launched of OMRON NE C106, an addition to their compressor nebulizer portfolio.
Inhalers And Nebulizers Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
23.2%
Largest Market
Asia Pacific
Fastest Growing Market
North America
Inhalers And Nebulizers Market Dynamics
The increasing prevalence of asthma and other respiratory diseases is driving the global inhalers and nebulizers market. There has been a rise in these conditions due to various factors such as increasing consumption of cigarettes, increasing air pollution, and unhealthy lifestyles. According to the World Health Organization (WHO), asthma affected an estimated 262 million people in 2019 and caused 455 000 deaths worldwide. The increasing prevalence of respiratory disorders is common in emerging countries such as India and Japan. Hence, it will boost global market growth.
North America Got Significant Share
Inhalers And Nebulizers Market Regional Analysis
Based on regions, the market share is divided into North America, Asia-pacific, Europe, and the Middle East, and the African region. The inhalers and nebulizers market in North America is likely to hold a significant revenue share in 2022, and, in the following years, it is predicted to increase rapidly. It is attributed to the increasing prevalence of asthma and other chronic disorders, the high adoption rate of advanced technology, and the increasing demand for modern portable inhalers. Moreover, the global players in this region are influencing the market through new product launches and collaborations. Asia Specific region held a major market share in 2021 and is expected to witness the highest CAGR in the upcoming years due to improving healthcare infrastructure in emerging countries.
Latin America
Europe
Asia Pacific
Middle East
North America
Inhalers And Nebulizers Market Segmentation
By Product Type
By Modality
- Portable
- Table-top
By End User
- Hospitals
- Clinics
- Homecare Settings
- Others
Frequently Asked Questions
The inhalers and nebulizers market size is expected to be valued at USD 5,976.3 million in 2022.
The inhalers and nebulizers market is poised to grow at a significant CAGR of 23.2% from 2022 to 2028.
The leading players in the global inhalers and nebulizers market are Adherium Limited, Cohero Health Inc., AstraZeneca, Inc., Cognita Labs, LLC, GlaxoSmithKline Plc, Novartis AG, OPKO Health Inc., Philip Morris International Inc., Resmed Inc., Teva Pharmaceutical Industries, and Omron Healthcare.
Historic years considered for the market study are 2017 through 2021, 2021 is considered as the base year for market estimation and Seven years forecast presented from 2022 – 2028.
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
| 1. Executive Summary |
| 2. Global Inhalers and Nebulizers Market Introduction |
| 2.1. Global Inhalers and Nebulizers Market – Taxonomy |
| 2.2. Global Inhalers and Nebulizers Market – Definitions |
| 2.2.1. By Product Type |
| 2.2.2. By Modality |
| 2.2.3. By End User |
| 2.2.4. By Region |
| 3. Global Inhalers and Nebulizers Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Inhalers and Nebulizers Market Dynamic Factors - Impact Analysis |
| 3.6. Global Inhalers and Nebulizers Market – Competition Landscape |
| 3.7. Epidemiology |
| 4. Global Inhalers and Nebulizers Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Inhalers and Nebulizers Market, By Product Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1. Jet Nebulizer |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Ultrasonic Nebulizer |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Mesh Nebulizer |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Others |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Inhalers and Nebulizers Market, By Modality, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1. Portable |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Table-top |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Inhalers and Nebulizers Market, By End User, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Clinics |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Homecare Settings |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Inhalers and Nebulizers Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia-Pacific |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Middle East and Africa |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Inhalers and Nebulizers Market - Opportunity Analysis Index, By Product Type, By Modality, By End User, and Region, 2024 - 2030 |
| 9. North America Inhalers and Nebulizers Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Jet Nebulizer |
| 9.1.2. Ultrasonic Nebulizer |
| 9.1.3. Mesh Nebulizer |
| 9.1.4. Others |
| 9.2. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1. Portable |
| 9.2.2. Table-top |
| 9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Hospitals |
| 9.3.2. Clinics |
| 9.3.3. Homecare Settings |
| 9.3.4. Others |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.4.1. USA |
| 9.4.2. Canada |
| 9.5. North America Inhalers and Nebulizers Market - Opportunity Analysis Index, By Product Type, By Modality, By End User, and Country, 2024 - 2030 |
| 9.6. North America Inhalers and Nebulizers Market Dynamics – Trends |
| 10. Europe Inhalers and Nebulizers Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Jet Nebulizer |
| 10.1.2. Ultrasonic Nebulizer |
| 10.1.3. Mesh Nebulizer |
| 10.1.4. Others |
| 10.2. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Portable |
| 10.2.2. Table-top |
| 10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Hospitals |
| 10.3.2. Clinics |
| 10.3.3. Homecare Settings |
| 10.3.4. Others |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Germany |
| 10.4.2. UK |
| 10.4.3. France |
| 10.4.4. Spain |
| 10.4.5. Italy |
| 10.4.6. Rest of Europe |
| 10.5. Europe Inhalers and Nebulizers Market - Opportunity Analysis Index, By Product Type, By Modality, By End User, and Country, 2024 - 2030 |
| 10.6. Europe Inhalers and Nebulizers Market Dynamics – Trends |
| 11. Asia-Pacific Inhalers and Nebulizers Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 11.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Jet Nebulizer |
| 11.1.2. Ultrasonic Nebulizer |
| 11.1.3. Mesh Nebulizer |
| 11.1.4. Others |
| 11.2. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Portable |
| 11.2.2. Table-top |
| 11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Hospitals |
| 11.3.2. Clinics |
| 11.3.3. Homecare Settings |
| 11.3.4. Others |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. China |
| 11.4.2. India |
| 11.4.3. Japan |
| 11.4.4. ASEAN |
| 11.4.5. Australia and New Zealand |
| 11.4.6. Rest of Asia-Pacific |
| 11.5. Asia-Pacific Inhalers and Nebulizers Market - Opportunity Analysis Index, By Product Type, By Modality, By End User, and Country, 2024 - 2030 |
| 11.6. Asia-Pacific Inhalers and Nebulizers Market Dynamics – Trends |
| 12. Latin America Inhalers and Nebulizers Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 12.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Jet Nebulizer |
| 12.1.2. Ultrasonic Nebulizer |
| 12.1.3. Mesh Nebulizer |
| 12.1.4. Others |
| 12.2. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Portable |
| 12.2.2. Table-top |
| 12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Hospitals |
| 12.3.2. Clinics |
| 12.3.3. Homecare Settings |
| 12.3.4. Others |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Brazil |
| 12.4.2. Mexico |
| 12.4.3. Rest of Latin America |
| 12.5. Latin America Inhalers and Nebulizers Market - Opportunity Analysis Index, By Product Type, By Modality, By End User, and Country, 2024 - 2030 |
| 12.6. Latin America Inhalers and Nebulizers Market Dynamics – Trends |
| 13. Middle East and Africa Inhalers and Nebulizers Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 13.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Jet Nebulizer |
| 13.1.2. Ultrasonic Nebulizer |
| 13.1.3. Mesh Nebulizer |
| 13.1.4. Others |
| 13.2. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Portable |
| 13.2.2. Table-top |
| 13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Hospitals |
| 13.3.2. Clinics |
| 13.3.3. Homecare Settings |
| 13.3.4. Others |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Gulf Cooperation Council (GCC) Countries |
| 13.4.2. South Africa |
| 13.4.3. Rest of MEA |
| 13.5. MEA Inhalers and Nebulizers Market - Opportunity Analysis Index, By Product Type, By Modality, By End User, and Country, 2024 - 2030 |
| 13.6. MEA Inhalers and Nebulizers Market Dynamics – Trends |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, Key Product Types, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. Adherium Limited |
| 14.2.2. Cohero Health Inc. |
| 14.2.3. AstraZeneca, Inc. |
| 14.2.4. Cognita Labs, LLC |
| 14.2.5. GlaxoSmithKline Plc |
| 14.2.6. Novartis AG |
| 14.2.7. OPKO Health Inc. |
| 14.2.8. Philip Morris International Inc. |
| 14.2.9. Resmed Inc. |
| 14.2.10. Teva Pharmaceutical Industries |
| 14.2.11. Omron Healthcare |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
- Adherium Limited
- Cohero Health Inc.
- AstraZeneca, Inc.
- Cognita Labs, LLC
- GlaxoSmithKline Plc
- Novartis AG
- OPKO Health Inc.
- Philip Morris International Inc.
- Resmed Inc.
- Teva Pharmaceutical Industries
- Omron Healthcare